Trial Outcomes & Findings for Development of Clinical Method to Triclosan Retention in Plaque Following Brushing (NCT NCT00762853)
NCT ID: NCT00762853
Last Updated: 2012-02-17
Results Overview
Triclosan is analyzed by gas chromatography (GC) with Atomic Emission Detection (480 nm) and quantitated by determining the ration of the peak height of triclosan to the peak height of an internal standard and relating the result to corresponding ratios of calibration standards.
COMPLETED
PHASE3
20 participants
12 hours
2012-02-17
Participant Flow
subjects were recruited by the PI at the clinical site
Subjects were screened for medical and oral health criteria and then began a 1 week washout period with fluoride toothpaste.
Participant milestones
| Measure |
Placebo First, Active Second
subjects brushed their teeth with Fluoride toothpaste (Placebo) during the first intervention, then brushed with the fluoride/triclosan (Active) toothpaste during the second intervention.
|
Active Toothpaste First, Then Placebo
Subjects brushed their teeth with the fluoride/triclosan(Active) toothpaste during the first intervention, then brushed with the fluoride alone toothpaste(placebo) during the second intervention.
|
|---|---|---|
|
First Treatment Period
STARTED
|
10
|
10
|
|
First Treatment Period
COMPLETED
|
10
|
10
|
|
First Treatment Period
NOT COMPLETED
|
0
|
0
|
|
1 Week Washout After Treatment 1
STARTED
|
10
|
10
|
|
1 Week Washout After Treatment 1
COMPLETED
|
10
|
10
|
|
1 Week Washout After Treatment 1
NOT COMPLETED
|
0
|
0
|
|
Second Treatment Period
STARTED
|
10
|
10
|
|
Second Treatment Period
COMPLETED
|
10
|
10
|
|
Second Treatment Period
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Development of Clinical Method to Triclosan Retention in Plaque Following Brushing
Baseline characteristics by cohort
| Measure |
Placebo First, Active Second
n=10 Participants
subjects brushed their teeth with Fluoride toothpaste (Placebo) during the first intervention, then brushed with the fluoride/triclosan (Active) toothpaste during the second intervention.
|
Active Toothpaste First, Then Placebo
n=10 Participants
Subjects brushed their teeth with the fluoride/triclosan(Active) toothpaste during the first intervention, then brushed with the fluoride alone toothpaste(placebo) during the second intervention.
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age Continuous
|
35.9 years
STANDARD_DEVIATION 11.9 • n=5 Participants
|
35.6 years
STANDARD_DEVIATION 9.9 • n=7 Participants
|
35.8 years
STANDARD_DEVIATION 10.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Region of Enrollment
Thailand
|
10 participants
n=5 Participants
|
10 participants
n=7 Participants
|
20 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 hoursTriclosan is analyzed by gas chromatography (GC) with Atomic Emission Detection (480 nm) and quantitated by determining the ration of the peak height of triclosan to the peak height of an internal standard and relating the result to corresponding ratios of calibration standards.
Outcome measures
| Measure |
Fluoride Toothpaste (Placebo)
n=20 Participants
fluoride only toothpaste
|
Active Toothpaste
n=20 Participants
fluoride/triclosan/copolymer(Active) toothpaste
|
|---|---|---|
|
Triclosan Concentration in Dental Plaque
|
0 ppm levels of triclosan
Standard Deviation 0
|
1.8 ppm levels of triclosan
Standard Deviation 1.2
|
Adverse Events
Placebo First, Active Second
Active Toothpaste First, Then Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60